文献速递妇科

子宫内膜癌保守治疗进展

Updates on Conservative Management of Endometrial Cancer.
PubMed 文献 · J Minim Invasive Gynecol · 2017-08-03

子宫内膜癌是美国最常见的妇科癌症,多见于绝经后女性,但年轻女性因肥胖和糖尿病等风险因素增加而发病率上升。对于有生育要求的患者,子宫切除和双侧输卵管卵巢切除术可能不理想,本文综述了激素治疗、宫腔镜局灶切除和宫内节育器等保留生育功能的保守治疗证据,并介绍了正在进行的前瞻性试验。

要点

  • 对于复杂非典型子宫内膜增生和I级子宫内膜癌患者,保守治疗是安全可行的。
  • 保留生育功能的选项包括激素治疗、宫腔镜局灶切除和宫内节育器。
  • 正在进行的展望性试验探索有医学合并症或希望保留生育力女性的保守治疗策略。

核心结论

  • 对于复杂非典型子宫内膜增生和I级子宫内膜癌患者,保守治疗是安全可行的。

研究设计与样本

  • 本文为综述,总结已发表的保留生育功能保守治疗证据,并介绍正在进行的前瞻性试验。

主要发现

  • 多项研究显示,在复杂非典型子宫内膜增生和I级子宫内膜癌患者中,保守治疗是安全可行的。
  • 保留生育功能的选项包括激素治疗、宫腔镜局灶切除和宫内节育器。
  • 正在进行的展望性试验探索有医学合并症或希望保留生育力女性的保守治疗策略。

临床怎么用

  • 对于有生育要求的子宫内膜癌患者,应与患者讨论保守治疗选项及每种方法的相关结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endometrial cancer is the most common gynecologic cancer in the United States. It is typically diagnosed in postmenopausal women. However, given the increasing incidence of risk factors such as obesity and diabetes in younger women, it is becoming a more prevalent problem in this age group. When endometrial cancer is diagnosed in patients of reproductive age, the standard surgical option of hysterectomy and bilateral salpingo-oophorectomy may not be ideal for women interested in future fertility. Hence, conservative options for select patients should be discussed along with the associated outcomes of each approach. A number of studies have shown that in patients with complex atypical endometrial hyperplasia and grade I endometrial carcinoma, a conservative approach is safe and feasible. The aim of this review is to summarize published evidence of fertility-sparing options such as hormonal therapy, hysteroscopic resection of focal lesions, and the role of intrauterine devices. We will also provide the latest updates on ongoing prospective trials that explore strategies for conservative management in women with medical comorbidities or those interested in fertility preservation.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Corzo C, Barrientos Santillan N, Westin SN, et al. Updates on Conservative Management of Endometrial Cancer. J Minim Invasive Gynecol. 2017. PMID: 28782618. doi:10.1016/j.jmig.2017.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。